As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Diseases like cancer or neurodegeneration are known to arise from genetic misfires. But treating such complex conditions hasn ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has ...

FORMS, AND YOU MAY HAVE HEARD OF SOME GENE MUTATIONS LIKE BRCA1 OR BRCA2, BUT THERE’S ANOTHER ONE THAT YOU MAY NOT HAVE HEARD OF, AND IT’S CHEK2. MERCY MEDICAL CENTER DOCTOR NEIL FRIEDMAN JOINS US NOW ...

At SGO 2026, Alison Schram, MD, highlighted first-in-class tumor suppressor reactivation and emphasized early NGS testing in ...

Sign up for Being Human, a newsletter that explores wellness culture, mortality and disease, and other mysteries of the body and the mind. “It’s a branding ...

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.

Mutations in a protein called KRAS fuel some of the most lethal cancers. Designing drugs to disable KRAS has proved ...

The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...

PYNNACLE enrolled heavily pretreated TP53 Y220C–mutant ovarian cancer (median four prior lines), including platinum-resistant ...

The Yvonne Ashley Galiber Breast Cancer Foundation will host its first Breast & Prostate Cancer Conference on St. Croix on ...